What is Jazz Pharmaceuticals's accrued interest?

Jazz Pharmaceuticals (JAZZ) reported accrued interest of $21.4M in Q1 2026.

How has Jazz Pharmaceuticals's accrued interest changed year-over-year?

Jazz Pharmaceuticals's accrued interest decreased by 0.4% year-over-year, from $21.49M to $21.4M.

What is the long-term trend for Jazz Pharmaceuticals's accrued interest?

Over 4 years (2021 to 2025), Jazz Pharmaceuticals's accrued interest has grown at a -4.4% compound annual growth rate (CAGR), from $48.64M to $40.7M.

Jazz Pharmaceuticals JAZZ Accrued interest

Accrued interest at other companies

Ionis PharmaceuticalsIONS

$26.04M—

Royalty PharmaRPRX

$25.3M+31.6%

BridgeBio PharmaBBIO

——

Neurocrine BiosciencesNBIX

——

ExelixisEXEL

——

Other financials

Income statement

See full

Revenue$1.1B+19.1%

Operating income$336.6M+702%

Net income$293.1M+417%

EPS (diluted)$4.43+391%

Balance sheet

See full

Cash & equivalents$667.5M-64.1%

Total debt$5.4B-0.1%

Total equity$4.5B+8.6%

Total assets$11.9B+2.8%

Cash flow

See full

Operating cash flow$408.2M-5.0%

CapEx$19.7M+41.7%

Free cash flow$388.5M-6.6%

Valuation

See full

Market cap$14.11B+54.4%

Enterprise value$18.85B+47.7%

P/S3.2×+0.9×

Profitability

See full

Operating margin-11.9%-28.1pp

Net margin-8.9%-20.5pp

FCF margin28.6%-8.6pp

Returns & leverage

See full

Return on equity-9.1%-21.2pp

Debt / equity1.2×-0.1×

Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestPayableCurrent.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's accrued interest?: Jazz Pharmaceuticals (JAZZ) reported accrued interest of $21.4M in Q1 2026.
How has Jazz Pharmaceuticals's accrued interest changed year-over-year?: Jazz Pharmaceuticals's accrued interest decreased by 0.4% year-over-year, from $21.49M to $21.4M.
What is the long-term trend for Jazz Pharmaceuticals's accrued interest?: Over 4 years (2021 to 2025), Jazz Pharmaceuticals's accrued interest has grown at a -4.4% compound annual growth rate (CAGR), from $48.64M to $40.7M.